Skip to evidence report

IPSC.mesodermal_primed: Studies — page 5

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 1,329 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 4,001–5,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for IPSC.mesodermal_primed
#Trait / studyIndividual trait IDMean IC score
4001Kela-code for severe mental illnessFING000007073.15
4002LDL (standard GWA)GCST902672723.15
4003Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T313ECGU0003133.15
4004Systolic blood pressureGCST903102943.15
4005Pulse pressureGCST904727853.15
4006Sphingomyelin_40:2_[M+H]1+ levelsGCST900603523.15
4007Disorders of skin appendagesFING000004603.15
4008GPNMB levelsGCST904693933.14
4009Hypertension, essentialFING000006383.14
4010Etiocholanolone glucuronide levelsGCST901999643.14
4011wg rh intensity-contrast parstriangularisGCST900038463.14
4012Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T387ECGA0003873.14
4013Average diameter for VLDL particlesGCST905002903.14
4014Retinal thickness (functional principal component 1)GCST904557213.13
4015IDP dMRI ProbtrackX L2 cgc rGCST900042783.13
4016T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 67)GCST903208863.13
4017LTBP2 levelsGCST904698143.13
4018IDP dMRI TBSS OD Cerebral peduncle LGCST900044173.13
4019Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T327ECGA0003273.13
4020Benign lipomatous neoplasm of skin and subcutaneous tissue of trunkFING000001503.13
4021Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T277ECGU0002773.13
4022Phospholipids in VLDLGCST905002683.12
4023Left-hemisphere salience/ventral attention network to caudate white-matter structural connectivityGCST903027203.12
4024Hereditary hemolytic anemias (PheCode 282)GCST904757793.12
4025Coronary atherosclerosis (PheCode 411.4)GCST900439573.12
4026Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T302ECGA0003023.12
4027Prescriptions - amlodipine | calcium channel blocker,dihydropyridine,anti-hypertensiveUKBB000006603.12
4028Hyphaema and other vascular disorders of iris and ciliary bodyFING000006473.12
4029Diastolic blood pressureGCST904727793.11
4030Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T388ECGA0003883.11
4031Principal component-derived dietary pattern 32GCST901330373.11
4032Gamma-CEHC levelsGCST901998643.10
4033EmphysemaFING000004963.10
4034Omega-3 fatty acids to total fatty acids percentageGCST905020813.10
4035IDP dMRI ProbtrackX FA fmiGCST900039363.10
4036aseg lh volume PutamenGCST900026223.10
4037Atherosclerosis of native arteries of the extremities with intermittent claudication (PheCode 440.22)GCST904759913.10
4038wg rh intensity-contrast inferiorparietalGCST900038343.10
4039CDH2/CDHR2 ratioGCST903139503.10
4040Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T333ECGA0003333.09
4041Non-cancer illness code, self-reported - angina | Medical conditionsUKBB000005053.09
4042Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T389ECGA0003893.09
4043Free Cholesterol to Total Lipids in Very Large VLDL percentageGCST905005983.09
4044DTI TBSS MD Fornix cres+Stria terminalis LGCST903846113.08
4045DTI TBSS L3 Uncinate fasciculus RGCST903845683.08
4046Triglycerides | Blood biochemistryUKBB000008613.08
4047Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T196ECGA0001963.07
4048wg lh intensity-contrast parsopercularisGCST900038093.07
4049ITGB1/TFPI ratioGCST903152313.07
4050FLT3 levelsGCST904692513.07
4051Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T334ECGA0003343.07
4052DSG4 levelsGCST904690443.06
4053SLC5A8 levelsGCST902428503.06
4054CystitisFING000003763.06
4055Hemorrhagic fever with renal syndromeGCST904541903.06
4056Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T173ECGU0001733.06
4057YES1 levelsGCST904710883.06
4058Diacylglycerol_36:4_[M+H-H2O]1+ levelsGCST900601883.05
4059MDK levelsGCST904698773.05
4060VEGFA levelsGCST900119953.05
4061Hyperparathyroidism (PheCode 252.1)GCST904756933.05
4062ULBP2 levelsGCST904710083.04
4063MIA/NBL1 ratioGCST903154453.04
4064SPINK6 levelsGCST904707253.04
4065Venous thromboembolismFING000014273.04
4066Cerebrovascular disease (PheCode 433)GCST904759853.04
4067T1 FreeSurfer aseg Left-choroid-plexusGCST903841563.04
4068Operative procedures - Fibreoptic endoscopic examination of upper gastrointestinal tract and biopsy of lesion of upper gastrointestinal tract | Summary OperationsUKBB000005783.04
4069Glucose | Blood biochemistryUKBB000002883.04
4070Red cell distribution widthGCST0068043.04
4071Other disorders of corneaFING000010223.03
4072IDP dMRI ProbtrackX L3 cst lGCST900043083.03
4073CXCL6/DFFA ratioGCST903143573.03
4074Triglyceride to HDL cholesterol ratioGCST902959493.03
4075Alcohol-related disorders | mental disordersUKBB000000263.03
4076DTI TBSS MD Superior corona radiata RGCST903845963.02
4077ISLR2 levelsGCST904696293.02
4078PI16 levelsGCST904702293.02
4079T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 118)GCST903209373.02
4080Irritable bowel syndromeGCST902439583.01
4081Plasma mannonate* levels in chronic kidney diseaseGCST902654793.01
4082high density lipoprotein cholesterol (HDLC, minimm, inv-norm transformed)GCST904753543.01
4083Other functional intestinal disordersFING000010523.00
4084Triglyceride levels in VLDLGCST900930033.00
4085Free cholesterol levels in chylomicrons and extremely large VLDLGCST900930443.00
4086RND3 levelsGCST906180663.00
4087DAPP1/ITGB1BP2 ratioGCST903143882.99
4088Mental and behavioural disorders due to use of tobacco | Mental and behavioural disorders due to psychoactive substance useUKBB000004602.99
4089Cholesteryl Esters to Total Lipids in Very Large VLDL percentageGCST905005692.98
4090Total lipid levels in very large VLDLGCST900930222.98
4091Other and unspecified nerve root and plexus disorders, also in other diseasesFING000009442.98
4092Principal component-derived dietary pattern 11GCST901330162.98
4093MITD1/RHOC ratioGCST903154532.98
4094IDP dMRI ProbtrackX ICVF slf lGCST900043962.98
4095IDP dMRI TBSS ICVF Uncinate fasciculus LGCST900043722.97
4096Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T169ECGU0001692.97
4097Severe hearing loss or partial deafness in one or both earsGCST904753852.97
4098BCAM/NOTCH1 ratioGCST903134742.97
4099CD40LG/EREG ratioGCST903138202.96
4100Total lipids in IDLGCST904975942.96
4101Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T454ECGA0004542.96
4102BCAM/CLEC14A ratioGCST903134702.96
4103wg lh intensity-contrast middletemporalGCST900038062.96
4104CX3CL1 levelsGCST902747782.96
4105IFNGR1/THBD ratioGCST903151302.95
4106Number of treatments/medications taken | MedicationsUKBB000005422.95
4107FOLH1 levelsGCST904256612.95
4108Left ventricular outflow tract obstruction, narrow definitionFING000007182.95
4109Polyunsaturated fatty acid levelsGCST904992662.95
4110IDP dMRI TBSS ICVF Anterior corona radiata LGCST900043502.95
4111DDR1/PVR ratioGCST903144422.95
4112Number of attempts | Prospective memoryUKBB000005312.94
4113Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T180ECGU0001802.94
4114AMY2B levelsGCST904682992.94
4115Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T407ECGU0004072.94
4116Phospholipids in large VLDL (UKB data field 23497)GCST902695942.94
4117IDP T1 SIENAX peripheral grey unnormalised volumeGCST900024272.94
4118Physical activity (confirmatory factor analysis Factor 23)GCST903093572.94
4119DTI TBSS L1 External capsule RGCST903844602.93
4120Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T374ECGU0003742.93
4121Left-hemisphere somatomotor network to right-hemisphere salience/ventral attention network white-matter structural connectivityGCST903026782.93
4122Diabetes mellitus (UKB data field 2443)GCST900436272.93
4123Right ventricular end systolic volumeGCST901345892.93
4124Linoleic acid levelsGCST905023072.93
4125aparc-Desikan rh area parsopercularisGCST900031242.92
4126Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T179ECGA0001792.92
4127Phospholipids to Total Lipids in IDL percentageGCST904976422.92
4128F-strong alcohol liking (derived food-liking factor)GCST900948502.92
4129Glycated hemoglobin levelsGCST900022432.92
4130SSC-A on plasmacytoid Dendritic CellGCST900020722.92
4131Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T314ECGU0003142.92
4132Atherosclerosis, excluding cerebral and coronary sclerosisFING000001232.92
4133Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T223ECGU0002232.92
41341-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0) levelsGCST902000832.92
4135Left ventricular wall thickness (mean)GCST904352642.91
4136GRN levelsGCST904694042.91
4137Vigorous physical activityGCST0060982.91
4138LBR/MAD1L1 ratioGCST903152952.91
4139Diacylglycerol_34:2_[M+H-H2O]1+ levelsGCST900601782.91
4140OSMR levelsGCST904701322.91
4141wg lh intensity-contrast superiorfrontalGCST900038192.91
4142CRELD1 levelsGCST904688582.91
4143Total lipids in large VLDL (UKB data field 23496)GCST902695932.91
4144aparc-Desikan rh volume parahippocampalGCST900028162.91
4145Systolic blood pressure, manual reading, adjusted by medication | Cardiovascular measurementUKBB000008112.91
4146Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T467ECGA0004672.91
4147Shoulder width to body height ratioGCST902702612.90
4148Osteoporosis (PheCode 743.1)GCST904763842.90
4149LRP11/NECTIN2 ratioGCST903153292.90
4150Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T195ECGA0001952.90
4151DAPK2 levelsGCST904689452.90
4152Low density lipoprotein cholesterol levelsGCST902396572.89
4153AV-blockFING000001372.89
4154Coronary artery calcificationGCST902784562.89
4155Alzheimer's disease (MTAG)GCST904490552.89
4156CDH17 levelsGCST904686692.89
4157APCS levelsGCST904284632.89
4158Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T16ECGU0000162.89
4159DTI TBSS FA Anterior corona radiata LGCST903844032.89
4160Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T466ECGA0004662.89
4161Medication use (salicylic acid and derivatives)GCST900187752.88
4162Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T261ECGA0002612.88
4163IGFBP1 levelsGCST904695272.88
4164Disorders of breastFING000004372.88
4165Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T168ECGU0001682.87
4166Handedness (confirmatory factor analysis Factor 36)GCST903093702.87
4167IDP dMRI TBSS L3 Body of corpus callosumGCST900041742.87
4168Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T409ECGU0004092.86
4169Plantar fascial fibromatosisFING000011692.86
4170DTI TBSS L3 Anterior limb of internal capsule LGCST903845412.86
4171FIS1/HSPA1A ratioGCST903148252.86
4172PM: initial answer - Blue square | Prospective memoryUKBB000006512.86
4173Female infertility, cervigal, vaginal, other or unspecified originFING000005382.86
4174IDP dMRI ProbtrackX MO atr rGCST900040032.86
4175Free cholesterol levels in very large VLDLGCST900930202.86
4176Monounsaturated fatty acid levelsGCST905023462.86
4177Other strabismusFING000011142.86
4178IDP T1 FAST ROIs R occ poleGCST900025462.86
4179Retinal thickness (functional principal component 6)GCST904557262.85
4180wg lh intensity-contrast fusiformGCST900037982.85
4181Phospholipids in very small VLDLGCST905008402.84
4182Other abnormal uterine and vaginal bleedingFING000009192.84
4183Other diseases of intestine | Other diseases of intestinesUKBB000006052.84
4184Mean corpuscular hemoglobin concentrationGCST900023912.84
4185ADGRE2/B4GALT1 ratioGCST903131742.83
4186DAPP1 levelsGCST904689462.83
4187aparc-DKTatlas rh volume parahippocampalGCST900029072.83
4188wg lh intensity-contrast superiortemporalGCST900038212.83
4189Placental weight (paternal genotype, adjusted for sex)GCST902751992.83
4190Ectopic pregnancyFING000004872.82
4191MAP2K6/TBL1X ratioGCST903153782.82
4192IDP dMRI TBSS MD Sagittal stratum RGCST900040572.82
4193Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T469ECGA0004692.82
4194RECK levelsGCST904704452.82
4195Other extrapyramidal and movement disorders in other diseasesFING000010472.82
4196Time spend outdoors in summer | Sun exposureUKBB000008172.82
4197Sleep disorders (PheCode 327)GCST904758232.81
4198Right-hemisphere default mode network to thalamus white-matter structural connectivityGCST903028442.81
4199SEPTIN3 levelsGCST904705762.81
4200Concentration of large VLDL particlesGCST900928752.81
4201Chronic Kidney Disease, Stage III (PheCode 585.33)GCST904761282.80
4202Linoleic acid to total fatty acids percentageGCST905023362.80
4203LDL cholesterol levelsGCST904983462.80
4204Duration of vigorous activity | Physical activityUKBB000001992.80
4205Total lipids in medium VLDLGCST904989942.80
4206Mean arterial pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurementUKBB000004402.80
4207Ever thought that life not worth living | Self-harm behavioursUKBB000002252.79
4208End-diastolic bi-ventricular shape (principal component 1)GCST904484802.79
4209aparc-DKTatlas rh area parsopercularisGCST900032812.79
4210PLSCR3 levelsGCST904702612.78
4211Blood cell traits latent factor 2 (red cell)GCST905592442.78
4212DNAJB14 levelsGCST904272352.78
4213Alcohol usually taken with meals (UKB data field 1618)GCST901330042.78
4214Hearing difficulty problems background noise (UKB data field 2257)GCST900428852.78
4215Bone marrow fat fraction of lumbar vertebra 1GCST906523862.78
4216Body-mass index, inverse-rank normalizedFING000002222.78
4217Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T235ECGU0002352.78
4218aseg lh intensity PallidumGCST900037712.78
4219Other eye problems | EyesightUKBB000006102.77
4220Total cholesterol minus HDL-C levelsGCST904991292.77
4221DTI autoptx L1 atr l tractGCST903851412.77
4222VCAN levelsGCST904710322.77
4223Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T170ECGU0001702.77
4224MBL2 levelsGCST904698682.77
4225SNCA levelsGCST904706942.77
4226AXIN1/MAP2K6 ratioGCST903134132.77
4227IDP dMRI TBSS ICVF Posterior thalamic radiation RGCST900043552.76
42283-(4-hydroxyphenyl)lactate levelsGCST902435752.76
4229Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T165ECGU0001652.76
4230SUGT1/TBL1X ratioGCST903158972.76
4231Retinoschisis and retinal cysts (PheCode 361.2)GCST904758462.76
4232Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T417ECGU0004172.76
4233Hypo-osmolality and hyponatraemiaFING000006482.76
4234T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 45)GCST903206082.75
4235Volume of right medial nucleusGCST904750422.75
4236Osteomyelitis (PheCode 710.1)GCST904762212.75
4237total creatine kinase (maximum, inv-norm transformed)GCST904764102.75
4238Monounsaturated fatty acids to total fatty acids percentageGCST905023882.75
4239CREG1/NAAA ratioGCST903142502.75
4240Triglyceride levels in medium HDLGCST900929022.75
4241HLA-A levelsGCST904694572.74
4242Hallux valgus (Bunion) (PheCode 735.3)GCST904762512.74
4243Cholesteryl ester_16:0_[M+NH4]1+ levelsGCST900602112.74
4244Platelet count during first trimester of pregnancyGCST903022242.74
4245SLITRK6 levelsGCST904706712.74
4246Systolic blood pressure, manual reading, adjusted by medication | Cardiovascular measurementUKBB000008122.73
4247Other septicaemiaFING000010972.73
4248SEMA4D/TXNDC5 ratioGCST903158242.73
4249Ground coffee consumptionGCST901329762.73
4250Hippocampal subfield right CA1 volume (head)GCST902679612.73
4251Phlebitis and thrombophlebitis of lower extremities (PheCode 451.2)GCST900440252.73
4252IDP T1 FIRST right putamen volumeGCST900024412.72
4253Hypermetropia (PheCode 367.8)GCST904758822.72
4254LRRC59 levelsGCST904698042.72
4255Right-hemisphere default mode network to caudate white-matter structural connectivityGCST903028452.72
4256Exophthalmic conditionsFING000005262.72
4257DMP1 levelsGCST904690072.72
4258CD244/GP1BA ratioGCST903137662.72
4259Left-hemisphere control network to right-hemisphere default mode network white-matter structural connectivityGCST903027512.72
4260Total testosterone levelsGCST900121142.72
4261Orange juice likingGCST900948062.72
4262GSTT2B levelsGCST904694152.72
4263Sodium in urine | Urine assaysUKBB000007852.71
4264HEXIM1/NUB1 ratioGCST903150492.71
4265Cerebral aneurysm, nonrupturedFING000002632.71
4266Apple juice likingGCST900946902.71
42671-stearoyl-2-docosahexaenoyl-gpc (18:0/22:6) levelsGCST902000462.71
4268Enterocolitis due to Clostridium difficileFING000005072.71
4269NGRN levelsGCST904700452.71
4270ThalamNuclei rh volume MDlGCST900027482.71
4271Mean arterial pressure, manual reading | Cardiovascular measurementUKBB000004422.71
4272Pain in limb (PheCode 773)GCST904762702.71
4273SNX18 levelsGCST904707002.70
4274Glutamine levelsGCST904972852.70
4275Corneal resistance factor (right) | Intraocular pressureUKBB000001512.70
4276T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 64)GCST903206272.70
4277Glucosamine medicationFING000005842.70
4278Erectile dysfunction [ED] (PheCode 605)GCST904761612.70
4279Physical decline (log-difference score)GCST905658472.69
4280Total lipids in medium HDLGCST904985972.69
4281Cerebral amyloid angiopathyFING000002622.69
4282Triglycerides in large LDL (UKB data field 23536)GCST902696332.69
4283DNA methylation Hannum age accelerationGCST900142892.69
4284ADGRE5 levelsGCST904682382.69
4285Cardiac pacemaker in situ (PheCode 426.91)GCST904759602.69
4286Testosterone | Blood biochemistryUKBB000008162.68
4287CALCOCO1/PFKFB2 ratioGCST903136082.68
4288Mean arterial pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurementUKBB000004392.68
4289Total lipids in chylomicrons and extremely large VLDL (UKB data field 23482)GCST902695792.68
4290DyslipidemiaGCST900860772.68
4291Prescriptions - alpha1-antagonist|alpha blockerUKBB000006592.68
4292aparc-DKTatlas lh area precuneusGCST900032572.67
4293EBAG9/EDAR ratioGCST903145632.67
4294FAM3C/NECTIN2 ratioGCST903147812.67
4295F9 levelsGCST904691722.67
4296Total fatty acid levelsGCST905022122.67
4297LGALS8 levelsGCST904697642.67
4298T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 106)GCST903209252.67
4299Clinical anxiety and depression (confirmatory factor analysis Factor 3)GCST903093382.67
4300Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T229ECGU0002292.66
4301Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T243ECGU0002432.66
4302CDKN2D/ITGB1BP2 ratioGCST903139872.66
4303Diastolic blood pressureGCST904727772.65
4304Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T461ECGA0004612.65
4305BCAM levelsGCST904684252.65
4306CD69/PPP1R2 ratioGCST903138822.65
4307Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T390ECGA0003902.65
4308Cholesterol in chylomicrons and extremely large VLDL (UKB data field 23484)GCST902695812.65
4309Free Cholesterol to Total Lipids in IDL percentageGCST904975792.65
4310Cholesterol in Small LDLGCST904995592.65
4311Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T188ECGA0001882.65
4312Abnormality of gait (PheCode 350.2)GCST904758412.64
4313ART3/GPC1 ratioGCST903133612.64
4314aseg global volume 3rd-VentricleGCST900025992.64
4315Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T398ECGU0003982.64
4316TPI1 levelsGCST900886592.64
4317Fluid intelligence score decline (log-difference score)GCST905658522.64
4318HPCAL1/NUDC ratioGCST903150742.64
4319TNFRSF11B/TNFSF11 ratioGCST903159302.63
4320Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T231ECGU0002312.63
43215,6-dihydrouridine levelsGCST901997672.63
4322Estradiol levelsGCST900200912.63
4323DDR1 levelsGCST904689702.63
4324Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T462ECGU0004622.63
4325AnginaGCST904681092.62
4326Fluid intelligence score (baseline)GCST905658422.62
4327OSCAR/TNFRSF14 ratioGCST903155882.62
4328CAG-776 sp000438195 abundance in stoolGCST900322962.62
4329CXADR/MME ratioGCST903143292.62
4330ARG1 levelsGCST904683502.62
4331Cataract | sense organsUKBB000001202.62
4332Excessive hairinessGCST0060952.62
43333-hydroxybutyrate levels (UKB data field 23474)GCST902695712.62
4334TNFRSF11A levelsGCST904709022.62
4335Concentration of very large VLDL particlesGCST900930232.61
4336HDL cholesterol levels (UKB data field 30760)GCST904680752.61
4337Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T291ECGU0002912.61
4338CDKN1A/ENO2 ratioGCST903139692.61
4339Total Phosphatidylethanolamine levelsGCST900252072.61
4340Bone marrow fat fraction of thoracic vertebra 10GCST906523822.61
4341Triglycerides in medium LDL (UKB data field 23543)GCST902696402.61
4342Androstenediol (3beta,17beta) disulfate (1) levelsGCST901998422.61
4343Antihypertensive medication - note that there are other indicationsFING000000972.61
4344wg lh intensity-contrast rostralmiddlefrontalGCST900038182.61
4345Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T459ECGA0004592.61
4346Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T415ECGA0004152.61
4347GPR37 levelsGCST904693972.60
4348CD244/CD84 ratioGCST903137622.60
4349SRC/STAT5B ratioGCST903158822.60
4350DiabetesGCST904681242.60
4351IDP dMRI ProbtrackX MD slf rGCST900042412.60
4352Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST904992872.59
4353Nephritis and nephropathy without mention of glomerulonephritis (PheCode 580.3)GCST904761152.59
4354Docosahexaenoic acid to total fatty acids percentageGCST905019972.59
4355Nap during day | SleepUKBB000004922.59
4356IDP dMRI ProbtrackX ISOVF fmiGCST900045362.58
4357CXCL1 levelsGCST900120192.58
4358Monounsaturated fatty acid levelsGCST904990902.58
4359MAVS/MED18 ratioGCST903153892.58
4360DTI autoptx FA ilf l tractGCST903851262.58
4361EndometriosisGCST900186192.58
4362Pure hypercholesterolaemiaFING000012302.58
4363CPXM1/DKK1 ratioGCST903142182.58
4364Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T478ECGU0004782.58
4365DTI TBSS FA Superior longitudinal fasciculus RGCST903844202.58
4366CAG-177 sp003538135 abundance in stoolGCST900322602.57
4367Phospholipids in very small VLDL (UKB data field 23518)GCST902696152.57
4368Total lipid levels in large VLDLGCST900928742.57
4369Phospholipids to total lipids ratio in very small VLDLGCST900930372.57
4370Saturated fatty acids to total fatty acids percentageGCST905027012.57
4371IDP dMRI ProbtrackX L2 ptr lGCST900042922.57
4372Left-hemisphere control network to left-hemisphere default mode network white-matter structural connectivityGCST903027442.57
4373Osteoarthrosis NOS (PheCode 740.9)GCST904762562.56
4374Frailty (Factor 4 - Metabolic Problems)GCST906240502.56
4375SDC1 levelsGCST904705582.56
4376Paroxysmal tachycardiaFING000011512.56
4377MGLL/PDLIM7 ratioGCST903154382.56
43781-palmitoyl-2-arachidonoyl-gpc (16:0/20:4n6) levelsGCST902006922.56
4379IZUMO4 levelsGCST904237922.56
4380CDON levelsGCST904686872.56
4381Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T14ECGU0000142.55
4382rfMRI amplitudes (ICA100 node 12)GCST900046002.55
4383AMBP/ASGR1 ratioGCST903132512.55
4384NH4_C22:4 Cholesteryl ester levels in chronic kidney diseaseGCST902572272.55
4385Triglycerides in VLDLGCST905003042.55
4386Red blood cell erythrocyte distribution width (UKB data field 30070)GCST904680992.55
4387Haemoglobin concentration (UKB data field 30020)GCST904680742.55
4388Triacylglycerol_52:1_[M+NH4]1+ levelsGCST900605152.55
4389Total triglycerides levelsGCST905001262.55
4390Cholesteryl Esters in LDLGCST904983742.54
4391Treatment or medication use - insulin product (UKB data field 20003_1140883066)GCST900422262.54
4392Volume of right basal nucleusGCST904750152.54
4393Acetoacetate levels (UKB data field 23476)GCST902695732.54
4394IDP dMRI ProbtrackX ICVF ilf lGCST900043892.54
4395Lactosyl-N-nervonoyl-sphingosine (d18:1/24:1) levelsGCST902000982.54
4396aparc-Desikan lh area precuneusGCST900030972.54
4397aseg global volume SupraTentorialNotVentGCST900025962.54
4398T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 50)GCST903206132.54
4399Free Cholesterol to Total Lipids in Large VLDL percentageGCST904982042.53
4400Illnesses of mother: Alzheimer's disease/dementia (UKB data field 20110_10)GCST900426782.53
4401Vascular/heart problems diagnosed by doctor - High blood pressure | Medical conditionsUKBB000008982.53
4402Mean corpuscular hemoglobin concentrationGCST900023282.53
4403Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T455ECGA0004552.53
4404IDP dMRI TBSS FA Anterior limb of internal capsule LGCST900038942.53
4405Eye problems/disorders - Cataract | EyesightUKBB000002302.52
4406Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T408ECGU0004082.52
4407CD40/GLOD4 ratioGCST903138142.52
4408COL1A1 levelsGCST904688132.52
4409BA-exvivo rh thickness BA1GCST900035272.52
4410End-diastolic bi-ventricular shape (principal component 10)GCST904484892.52
4411Concentration of medium HDL particlesGCST904986172.52
4412Other hearing lossFING000010562.51
4413Monounsaturated fatty acids levels (UKB data field 23447)GCST902695442.51
4414RCC1 levelsGCST904704432.51
4415CCL19 levelsGCST902747652.51
4416Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T413ECGA0004132.51
4417MANF/NCK2 ratioGCST903153592.51
4418MFGE8 levelsGCST904699002.51
4419Diseases of liverFING000004252.51
4420Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T234ECGA0002342.51
4421Saturated fatty acids levelsGCST905021942.51
4422IDP dMRI ProbtrackX L3 cst rGCST900043092.51
4423Docosahexaenoic acid levelsGCST905022432.51
4424Leiomyoma of uterusFING000007192.50
4425Bicuspidal aortic valve syndromeFING000002122.50
4426Left-hemisphere salience/ventral attention network to right-hemisphere dorsal attention network white-matter structural connectivityGCST903027142.50
4427Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T406ECGU0004062.50
4428aseg rh volume CaudateGCST900026382.49
4429Concentration of chylomicrons and extremely large VLDL particles (UKB data field 23481)GCST902695782.49
4430Concentration of chylomicrons and extremely large VLDL particlesGCST905010102.49
4431Acute alcohol intoxicationFING000000142.49
4432Metabolic syndromeGCST0096022.49
4433BLVRB/HMBS ratioGCST903135262.49
4434GALNT10/SEMA7A ratioGCST903149152.48
4435Cereal consumption (bowls per week) (UKB data field 1458)GCST901329822.48
4436HerniaFING000006162.48
4437IMPA1/TBCC ratioGCST903151752.48
4438Principal component-derived dietary pattern 17GCST901330222.48
4439Diastolic blood pressureGCST900187322.48
4440aparc-Desikan rh area inferiorparietalGCST900031142.48
4441NeuroticismGCST0052322.47
4442Phospholipids to total lipids in large HDL percentage (UKB data field 23634)GCST902697312.47
4443Sphingomyelin_40:3_[M+H]1+ levelsGCST900603482.47
4444Blood glucose levelsGCST900259862.47
4445BA-exvivo lh area BA2GCST900032082.47
4446Operative procedures - Insertion of prosthetic replacement for lens NEC | Summary OperationsUKBB000005832.47
4447Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T472ECGU0004722.47
4448Hippocampal subfield left CA3 volume (head)GCST902679412.47
4449Gestational thrombocytopeniaGCST903022342.46
4450Random glucose levelsGCST902715572.46
4451DTI autoptx L1 ilf l tractGCST903851532.46
4452Osteoarthrosis (PheCode 740)GCST904762532.46
4453NELL1 levelsGCST902424812.46
4454DTI TBSS L3 Anterior limb of internal capsule RGCST903845402.46
4455T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 7)GCST903205702.46
4456Total fatty acid levelsGCST905022182.45
4457ATP5IF1/LYN ratioGCST903133892.45
4458RET levelsGCST904704582.45
4459Phospholipid levels in very large VLDLGCST900930242.45
4460Illnesses of mother - None of the above (group 1) | Family historyUKBB000003492.45
4461aparc-a2009s rh volume S-subparietalGCST900030692.45
4462Cholesteryl Esters to Total Lipids in IDL percentageGCST904975492.45
4463Cholesteryl Esters to Total Lipids in Medium VLDL percentageGCST904989562.45
4464Cod likingGCST900947362.45
4465GFER/TRIAP1 ratioGCST903149212.45
4466ADIPOQ levelsGCST904682452.45
4467CTSZ levelsGCST904689182.45
4468Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T292ECGU0002922.44
4469T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 71)GCST903206342.44
4470aparc-Desikan rh volume parsopercularisGCST900028182.44
4471Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T161ECGU0001612.44
4472SpermatoceleFING000013192.44
4473Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T185ECGA0001852.43
4474EDAR/YES1 ratioGCST903145942.43
4475Never eat eggs, dairy, wheat, sugar - Sugar or foods/drinks containing sugar | DietUKBB000005012.43
4476Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T270ECGU0002702.43
4477Total Lipids in LDLGCST904983962.43
4478HEXIM1 levelsGCST904694472.43
4479T1 FIRST volume R PutaGCST903839952.43
4480Cholesterol to total lipids in large LDL percentage (UKB data field 23615)GCST902697122.42
4481Triglycerides to Total Lipids in Large VLDL percentageGCST904982932.42
4482CPM/PCSK9 ratioGCST903142162.42
4483Mineral and other dietary supplements - Glucosamine | MedicationUKBB000004732.42
4484GALNT7 levelsGCST904692992.42
4485Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T289ECGU0002892.42
4486Red blood cell countGCST900023642.41
4487Pulmonary embolism and infarction, acute (PheCode 415.11)GCST904759462.41
4488Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T473ECGU0004732.41
4489HippSubfield rh volume Whole-hippocampal-bodyGCST900027092.41
4490Alcohol likingGCST900946882.41
4491Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T484ECGU0004842.41
4492Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T373ECGU0003732.41
4493VSTM2L levelsGCST904710572.41
4494Falls in the last year | General healthUKBB000002352.40
4495OLR1 levelsGCST900120202.40
4496Total triglycerides levelsGCST900929922.40
4497Occupational creativityGCST903087742.40
4498Statin medicationFING000013312.39
4499NTF4 levelsGCST904700952.39
4500DTI TBSS MD Superior longitudinal fasciculus LGCST903846132.39
4501Triglycerides x depression interaction (2df test)GCST905706792.39
4502Gonarthrosis, primary, with knee surgeryFING000005862.39
4503Saturated fatty acids to total fatty acids percentageGCST905022072.39
4504Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905009292.39
4505PTGDS levelsGCST904703682.38
4506aparc-Desikan lh area fusiformGCST900030792.38
4507FURIN/INHBC ratioGCST903148862.38
4508Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T294ECGA0002942.38
4509Biliary atresiaGCST902964842.38
4510TNXB levelsGCST904709302.38
4511IDP dMRI TBSS ISOVF Superior longitudinal fasciculus RGCST900045172.38
4512Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T424ECGU0004242.38
4513PGA4 levelsGCST904702162.38
4514NTRK3/SCARF2 ratioGCST903155712.38
4515aparc-a2009s lh area S-postcentralGCST900033632.37
4516IGLL1 levelsGCST902414732.37
4517Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T17ECGU0000172.37
4518Dementia, including avohilmoFING000003952.36
4519Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T391ECGA0003912.36
4520Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T255ECGU0002552.36
4521Illnesses of father - None of the above (group 1) | Family historyUKBB000003452.36
4522Concentration of chylomicrons and extremely large VLDL particlesGCST905010152.35
4523Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905009922.35
4524Cooked vegetables consumptionGCST901329772.35
4525THBD levelsGCST904708532.35
4526Cholesterol to Total Lipids in IDL percentageGCST904975182.35
4527Prostate cancerGCST904751852.35
4528Endometriosis of rectovaginal septum and vaginaFING000005032.35
4529Omega-6 fatty acid levelsGCST905021032.35
4530GHR levelsGCST904693422.35
4531Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T79ECGU0000792.35
4532Systolic blood pressure (BMI unadjusted)GCST903351622.35
4533ANXA11 levelsGCST904683152.35
4534DTI TBSS L2 Posterior corona radiata RGCST903845022.34
4535Docosahexaenoic acid levelsGCST905019842.34
4536Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T405ECGU0004052.34
4537F-savour/caloric food liking (derived food-liking factor)GCST900948352.34
4538Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T178ECGA0001782.34
4539Bread type - Wholemeal or wholegrain | DietUKBB000001072.34
4540IDP dMRI TBSS L1 Superior longitudinal fasciculus RGCST900041152.34
4541Phospholipids in small HDLGCST904994782.34
4542EREG/GYS1 ratioGCST903147012.33
4543Left-hemisphere somatomotor network to left-hemisphere control network white-matter structural connectivityGCST903026732.33
4544SLIT2 levelsGCST904706682.33
4545Fresh fruit consumptionGCST901329792.33
4546Urinary incontinence (PheCode 599.4)GCST904761522.33
4547Cholesterol in Small VLDLGCST904997462.33
4548HRG levelsGCST904694762.33
4549T1 CAT volume L PlanumPolareGCST903840862.33
4550aseg lh intensity Lateral-VentricleGCST900037642.33
4551T1 FreeSurfer a2009s lh G precentral volumeGCST903848442.32
4552CALCOCO1 levelsGCST904685302.32
4553F-caffeinated/sweet liking (derived food-liking factor)GCST900947202.32
4554Cerebrospinal fluid sulfate* levelsGCST903180562.32
4555Phospholipid levels in chylomicrons and extremely large VLDLGCST905010312.32
4556C2/SSC5D ratioGCST903135552.32
4557Cholesterol to Total Lipids in Medium VLDL percentageGCST904989192.32
4558Red cell distribution widthGCST900024042.32
4559Getting up in morning | SleepUKBB000002852.32
4560CDKN1A/FOXO1 ratioGCST903139702.32
4561Phospholipids to Total Lipids in Large VLDL percentageGCST904982522.32
4562Volume of right paralaminar nucleusGCST904750512.32
4563HemoglobinGCST902786312.32
4564FOXO3/MAP3K5 ratioGCST903148802.31
4565Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905010452.31
4566Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T244ECGU0002442.31
4567Chronic ischaemic heart disease | Ischaemic heart diseasesUKBB000001372.30
4568Paradoxical eczema in biologic-treated plaque psoriasisGCST901625502.30
4569OsteoarthritisGCST904681442.30
4570DTI TBSS MO Pontine crossing tractGCST903846212.30
4571Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905009202.30
4572APOM/ERBB3 ratioGCST903133142.30
4573Percentage of trisyalated structures in total plasma glycans (GP97)GCST906685412.29
4574IDP dMRI TBSS FA Body of corpus callosumGCST900038802.29
4575T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 2)GCST903205652.29
4576End-diastolic bi-ventricular shape (principal component 8)GCST904484872.29
4577Principal component-derived dietary pattern 29GCST901330342.28
4578IDP T1 FAST ROIs R cerebellum VIIIbGCST900025832.28
4579Red blood cell (erythrocyte) distribution width | Blood countUKBB000007482.28
4580ITGB1BP2 levelsGCST904696422.28
4581Total testosterone levelsGCST900121122.28
4582Total lipids in very small VLDL (UKB data field 23517)GCST902696142.28
4583Low hand grip strength (60 years and older) (EWGSOP)GCST900075272.28
4584PM: initial answer - Orange circle| Prospective memoryUKBB000006522.27
4585CRYBB2 levelsGCST904688752.27
4586aparc-a2009s rh volume S-front-infGCST900030502.27
4587T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 39)GCST903208582.26
4588Coronary artery bypass graftingFING000003582.26
4589Platelet count at deliveryGCST903022272.26
4590X-24947 levelsGCST902006512.26
4591Linoleic acid to total fatty acids percentageGCST905023322.26
4592PSAPL1 levelsGCST902423542.26
4593Other disorders of stomach and duodenum (PheCode 537)GCST904760542.25
4594Age at onset of walkingGCST906510782.25
4595IDP dMRI TBSS MO Cerebral peduncle RGCST900039662.25
4596KLK14 levelsGCST904697002.25
4597SPINK4 levelsGCST904707232.25
4598AmygNuclei lh volume Lateral-nucleusGCST900026482.25
4599Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T414ECGA0004142.24
4600Triglyceride levels in small VLDLGCST900929782.24
4601Knee extension strengthGCST903195022.24
4602Diabetes (standard GWA)GCST902672782.24
46033-Hydroxybutyrate levelsGCST900928112.24
4604aparc-pial rh area lingualGCST900031862.24
4605Tobacco use disorder | mental disordersUKBB000008242.24
4606Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905009832.24
4607ICD10 O24.4: Diabetes mellitus arising in pregnancyGCST904542362.23
4608CDHR2 levelsGCST904686792.23
4609aseg lh volume choroid-plexusGCST900026292.23
4610Triglycerides to Total Lipids in Very Large VLDL percentageGCST905006922.23
4611BTN2A1/SMOC2 ratioGCST903135492.23
4612Biological Father: Coronary Artery / Coronary Heart DiseaseGCST904752412.23
4613Diaphragmatic hernia | digestiveUKBB000001712.22
4614Androstenediol (3beta,17beta) monosulfate (1) levelsGCST901998722.22
4615LILRA5 levelsGCST904697742.22
4616Holdemania abundance in stoolGCST900324322.22
4617Cough (PheCode 512.8)GCST904760412.22
4618NUB1 levelsGCST904700992.22
4619LGALS1/LGALS8 ratioGCST903153142.22
4620Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T412ECGA0004122.22
4621Triglycerides to Total Lipids in Large VLDL percentageGCST904982872.22
4622PLA2G4A/PPP1R12A ratioGCST903156662.22
4623HemoglobinGCST900023842.22
4624Colorectal cancer (PheCode 153)GCST904755662.21
4625rfMRI connectivity ICA-features 3GCST900063412.21
4626wg rh intensity-contrast parsopercularisGCST900038442.21
4627Left-hemisphere control network to right-hemisphere control network white-matter structural connectivityGCST903027502.21
4628Nonalcoholic fatty liver diseaseGCST900910332.21
4629Cholesterol levels in chylomicrons and extremely large VLDLGCST905009052.21
4630CPA1/PRSS2 ratioGCST903142062.21
4631Phospholipids in chylomicrons and extremely large VLDL (UKB data field 23483)GCST902695802.21
4632Left-hemisphere default mode network to caudate white-matter structural connectivityGCST903027682.20
4633GFER levelsGCST904693262.20
4634CCN3/FAP ratioGCST903137212.20
4635MRAP levelsGCST900899102.20
4636Principal component-derived dietary pattern 39GCST901330442.20
4637PHYKPL levelsGCST904702282.20
4638Educational attainmentGCST0025982.20
4639aseg lh intensity Cerebellum-CortexGCST900037672.20
4640Left-hemisphere visual network to left-hemisphere salience/ventral attention network white-matter structural connectivityGCST903026512.19
4641DTI autoptx L2 cgc r tractGCST903851712.19
4642IDP dMRI ProbtrackX OD ilf rGCST900044652.19
4643Cancer (UKB data field 2453)GCST900436282.19
4644IL1B levelsGCST904695702.19
4645Triglycerides to total lipids in medium HDL percentage (UKB data field 23643)GCST902697402.19
4646Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T238ECGU0002382.19
4647CHGA levelsGCST904687412.19
4648CLEC14A/TNFRSF21 ratioGCST903140822.19
4649SKAP1 levelsGCST904706452.18
4650Melanoma in situ (controls excluding all cancers)FING000008032.18
4651Calcific tendinitis of shoulderFING000002352.18
4652P4HB/PPP1R12A ratioGCST903155912.18
4653IDP dMRI ProbtrackX ISOVF unc lGCST900045502.17
4654Current employment status - Doing unpaid or voluntary work | EmploymentUKBB000001572.17
4655Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905009582.17
4656IL1RAP levelsGCST904695732.17
4657Never eat eggs, dairy, wheat, sugar - I eat all of the above | DietUKBB000005002.17
4658Serine levelsGCST902004152.17
4659Mean corpuscular hemoglobin concentrationGCST900023292.17
4660aseg global volume CSFGCST900026032.17
4661Phospholipids in IDLGCST904976282.17
4662aparc-a2009s lh volume G-parietal-supGCST900029512.17
4663Cholesteryl esters to total lipids in medium HDL percentage (UKB data field 23641)GCST902697382.16
4664Glaucoma, exfoliationFING000005802.16
4665Free androgen indexGCST902398232.16
4666Abnormal results of function study of liver (PheCode 573.7)GCST904760972.15
4667Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T221ECGU0002212.15
4668Non-cancer illness code, self-reported - hypertension | Medical conditionsUKBB000005172.15
4669Lymphoid neoplasmsGCST906247432.15
4670Open wound of foot except toe(s) alone (PheCode 871.3)GCST904762862.15
4671TXNDC5 levelsGCST904709912.15
4672Diverticulitis (PheCode 562.2)GCST904760772.15
4673COL6A3/NBL1 ratioGCST903141762.15
4674Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T384ECGU0003842.15
4675Cholesterol to total lipids in large VLDL percentage (UKB data field 23590)GCST902696872.15
4676Stress incontinence, female | genitourinaryUKBB000007972.14
4677T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 92)GCST903209112.14
4678ASAH2 levelsGCST902420982.14
4679T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 59)GCST903208782.14
4680PPP1R14D levelsGCST904703032.14
4681Acne (PheCode 706.1)GCST904762112.14
4682Unstable angina pectorisFING000014052.13
4683Plasma ascorbic acid 2-sulfate levels in chronic kidney diseaseGCST902648322.13
4684CDKN1A/FXN ratioGCST903139712.13
4685Pustulosis palmaris et plantarisFING000012332.13
4686Hearing difficultyGCST902457742.13
4687Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905010502.13
4688aseg global intensity 4th-VentricleGCST900037522.13
4689Triglycerides in medium HDL (UKB data field 23571)GCST902696682.13
4690Bone marrow fat fraction of thoracic vertebra 9GCST906523812.13
4691Fracture of upper limb (PheCode 803)GCST904762792.13
4692IDP dMRI ProbtrackX OD slf lGCST900044712.13
4693Cholesteryl Esters in IDLGCST904975232.13
4694BA-exvivo rh area BA4pGCST900032262.13
4695Aplastic anemia (PheCode 284)GCST904757832.13
4696Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T404ECGU0004042.13
4697Other chronic ischemic heart disease, unspecified | circulatory systemUKBB000006032.12
4698FOLR2/MSR1 ratioGCST903148662.12
4699Phosphatidylcholine-O_32:1_[M+H]1+/Phosphatidylcholine-P_32:0_[M+H]1+/Phosphatidylethanolamine-O_35:1_[M+H]1+ levelsGCST900602542.12
4700Feeling tenseGCST0069522.12
4701Monounsaturated fatty acid levelsGCST900929282.12
4702HemoglobinGCST900187372.12
4703Osteoporosis NOS (PheCode 743.11)GCST904762602.12
4704Current SmokerFING000003712.12
4705Concentration of very small VLDL particles (UKB data field 23516)GCST902696132.12
4706T1 FreeSurfer pial rh pericalcarine areaGCST903858422.11
4707T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 57)GCST903206202.11
4708Nonspecific chest pain (PheCode 418)GCST904759472.11
4709IDP dMRI TBSS ICVF Sagittal stratum RGCST900043572.11
4710IDP dMRI TBSS MD Cingulum hippocampus LGCST900040642.11
4711GGH/INHBC ratioGCST903149282.11
4712Triglycerides to Total Lipids in Very Large VLDL percentageGCST905006952.11
4713DTI autoptx FA ifo r tractGCST903851252.11
4714DNER levelsGCST902747852.11
4715Metabolonic lactone sulfate levelsGCST902002572.11
4716CCBL2 levelsGCST902417222.11
4717Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T69ECGA0000692.11
4718Left bundle branch block (PheCode 426.32)GCST904759582.11
4719Left-hemisphere somatomotor network to amygdala white-matter structural connectivityGCST903026872.10
4720aseg lh intensity VentralDCGCST900037752.10
4721aseg global volume 4th-VentricleGCST900026002.10
4722Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T381ECGU0003812.10
4723Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T383ECGU0003832.10
4724ROBO2/SCARF2 ratioGCST903157842.10
4725Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T430ECGU0004302.09
4726Ratio of triglycerides to phosphoglyceridesGCST900929832.09
4727Diacylglycerol_36:2_[M+H-H2O]1+ levelsGCST900601912.09
4728Shoulder lesions | Other soft tissue disordersUKBB000007692.09
4729SMOC2 levelsGCST904706832.09
4730IDP dMRI TBSS L2 Body of corpus callosumGCST900041262.09
4731IDP dMRI ProbtrackX ISOVF ilf rGCST900045402.09
4732Osteoporosis (PheCode 743.1)GCST904762592.09
4733DTI TBSS L2 Splenium of corpus callosumGCST903844802.09
4734Colon cancer/rectal cancerGCST904751702.08
4735Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905009562.08
4736IDP dMRI TBSS FA Superior corona radiata RGCST900039012.08
4737Medication use (vasodilators used in cardiac diseases)GCST900187632.08
4738GBA1 levelsGCST904232622.08
4739Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T187ECGU0001872.08
4740Autorefraction - 6mm asymmetry angle (left) | EyesightUKBB000000722.08
4741Succinoyltaurine levelsGCST902002352.08
4742Autorefraction - 3mm cylindrical power angle (left) | EyesightUKBB000000642.07
4743PRKG1 levelsGCST904703302.07
4744Non-cancer illness code, self-reported - kidney stone/ureter stone/bladder stone | Medical conditionsUKBB000005192.07
4745PNLIPRP1 levelsGCST904702732.07
4746TDGF1 levelsGCST904708242.07
4747Right ventricular peak ejection rateGCST902681202.07
4748Dermatophytosis of nail (PheCode 110.11)GCST904755622.07
4749Cholesterol to Total Lipids in Large VLDL percentageGCST904981252.07
4750CD300LG/CLEC14A ratioGCST903138012.07
4751IDP T1 FAST ROIs R cerebellum XGCST900025892.06
4752Phlebitis and thrombophlebitis of lower extremities (PheCode 451.2)GCST904760042.06
4753Fibrosis and cirrhosis of liverFING000005432.06
4754wg rh intensity-contrast caudalmiddlefrontalGCST900038302.06
4755CLEC5A levelsGCST904687762.06
4756mean corpuscular hemoglobin concentration (MCHC, maximum, inv-norm transformed)GCST904754542.06
4757Salt added to food | DietUKBB000007622.06
4758HYOU1/TGFBR3 ratioGCST903151052.05
4759T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 82)GCST903206452.05
4760Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T191ECGU0001912.05
4761Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T398ECGA0003982.05
4762Cerebrospinal fluid unidentified metabolite levels (HILIC Metabolomics ID: 3.04_132.06)GCST902915822.05
4763T1 CAT volume L LateralOccipitalCortexinferiordivisionGCST903840442.05
4764T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 42)GCST903208612.05
4765Non-oily fish consumptionGCST901329942.04
4766FCER1A levelsGCST904691982.04
4767Triglycerides in medium VLDL (UKB data field 23508)GCST902696052.04
4768Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T181ECGU0001812.04
4769Phospholipids to Total Lipids in Very Large VLDL percentageGCST905006652.04
4770Triglyceride levels (UKB data field 30870)GCST904681062.04
4771Left molecular layer hippocampal volume (body)GCST902679532.04
4772Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T174ECGU0001742.04
4773CA1/CA2 ratioGCST903135712.04
4774Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T392ECGA0003922.04
4775Red cell distribution widthGCST900023692.04
4776Coronary angioplastyFING000003572.03
4777IDP dMRI TBSS ISOVF Posterior thalamic radiation RGCST900045052.03
4778FST levelsGCST904692732.03
4779Coronary atherosclerosis | circulatory systemUKBB000001522.03
4780Parental longevity (mother's attained age)GCST0066962.03
4781Dermatochalasis (PheCode 374.6)GCST904758942.02
4782Frontal QRS-T angleGCST902463212.02
4783aparc-a2009s lh thickness G-cuneusGCST900036132.02
4784ACY1/DCXR ratioGCST903131622.02
4785aparc-Desikan rh thickness GlobalMeanThicknessGCST900034792.02
4786Free cholesterol in large VLDL (UKB data field 23500)GCST902695972.02
4787NPY/SMOC1 ratioGCST903155512.01
4788IDP dMRI TBSS L1 Superior longitudinal fasciculus LGCST900041162.01
4789IDP dMRI TBSS OD Cerebral peduncle RGCST900044162.01
4790Triglyceride levels in small HDLGCST900929542.01
4791aparc-DKTatlas lh area lingualGCST900032452.01
4792Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T397ECGA0003972.01
4793Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T418ECGU0004182.01
4794Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T380ECGU0003802.01
4795Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T397ECGU0003972.01
4796TSPAN8 levelsGCST904709802.01
4797COMP/ITGAV ratioGCST903141902.00
4798KLK8 levelsGCST902416802.00
4799SRC/TBL1X ratioGCST903158842.00
4800BANK1/FOXO1 ratioGCST903134562.00
4801Aplastic anemiaGCST900185742.00
4802Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T230ECGU0002302.00
4803APEX1 levelsGCST904683292.00
4804S100A4/SNAP29 ratioGCST903158012.00
4805ICD10 N92: Excessive, frequent and irregular menstruationGCST904542212.00
4806Free cholesterol in chylomicrons and extremely large VLDL (UKB data field 23486)GCST902695832.00
4807THY1 levelsGCST904708611.99
4808Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T382ECGU0003821.99
4809EDIL3 levelsGCST904690721.99
4810Triglyceride to HDL cholesterol ratioGCST902959501.99
4811Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T461ECGU0004611.98
4812FBP1 levelsGCST904691951.98
4813GGT1 levelsGCST904693361.98
4814Treatment/medication code - lansoprazole | MedicationsUKBB000008481.98
4815wg rh intensity-contrast superiorfrontalGCST900038541.98
4816Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T232ECGA0002321.97
4817Cholesterol in Large VLDLGCST904981191.97
4818Urine dimethylglycine levels in chronic kidney diseaseGCST902650451.97
4819CALCOCO1/DCTN1 ratioGCST903136001.97
4820Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T403ECGU0004031.97
4821CXADR/GGT1 ratioGCST903143281.97
4822ART3/RGMA ratioGCST903133621.97
4823Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T457ECGA0004571.97
4824MAPK9 levelsGCST904698571.97
4825ADGRE5/VCAM1 ratioGCST903131841.97
4826ENO2/TXNDC5 ratioGCST903146711.96
4827wg rh intensity-contrast temporalpoleGCST900038591.96
4828wg lh intensity-contrast lingualGCST900038041.96
4829Attention deficit hyperactivity disorder (ADuLT model adjusted for sex)GCST902751361.96
4830IDP dMRI ProbtrackX ICVF ifo rGCST900043881.96
4831aparc-DKTatlas rh volume parsopercularisGCST900029091.96
4832Pelvic organ prolapseGCST901024701.96
4833PPP1R14A levelsGCST904703021.96
4834Types of transport used (excluding work) - Cycle | Physical activityUKBB000008771.96
4835Total fatty acid levelsGCST905027271.95
4836CNTN3/NCS1 ratioGCST903141651.95
4837IDP dMRI TBSS OD External capsule RGCST900044341.95
4838Frailty (Factor 2 - Unhealthy Lifestyle)GCST906240481.95
4839ZBTB16 levelsGCST904710951.95
4840Autorefraction - 6mm asymmetry index (right) | EyesightUKBB000000741.95
4841total creatine kinase (minimum, inv-norm transformed)GCST904764161.95
4842ANPEP/CXADR ratioGCST903132721.95
4843PLAU levelsGCST904702521.95
4844Total Lipids in VLDLGCST905002341.94
4845aparc-DKTatlas rh area lingualGCST900032761.94
4846X-21467 levelsGCST902005941.94
4847Ventral herniaFING000014281.94
4848Fractured bone site(s) - Wrist | Medical conditionsUKBB000002571.94
4849mean corpuscular hemoglobin concentration (MCHC, minimum, inv-norm transformed)GCST904754621.94
4850CD27/TNFRSF13B ratioGCST903137771.94
4851N-acetylmethionine levelsGCST902002891.94
4852MINK1 levelsGCST904699091.93
4853SDK2 levelsGCST904705621.93
4854Attention deficit hyperactivity disorderGCST0053621.93
4855Triglycerides to Total Lipids in Medium HDL percentageGCST904986891.93
4856PVR levelsGCST904703941.93
4857IDP dMRI ProbtrackX FA ar rGCST900039261.93
4858SYT1 levelsGCST904707941.93
4859Diabetes diagnosed by doctor | Medical conditionsUKBB000001681.93
4860NUCB2/TXNDC5 ratioGCST903155781.93
4861PROC levelsGCST904703351.93
4862Autorefraction - 3mm weak meridian angle (left) | EyesightUKBB000000711.93
4863Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T481ECGU0004811.93
4864PDCD6 levelsGCST904701831.92
4865Colon cancer (PheCode 153.2)GCST904755671.92
4866Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T469ECGU0004691.92
4867S100A11/SERPINB8 ratioGCST903157991.92
4868DNAJB1/SIRT2 ratioGCST903145111.92
4869HematocritGCST900023041.92
4870GFRA3 levelsGCST904693301.92
4871Left-hemisphere limbic network to right-hemisphere default mode network white-matter structural connectivityGCST903027351.92
4872Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T468ECGA0004681.92
4873MPHOSPH8/PSRC1 ratioGCST903154781.92
4874Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T183ECGU0001831.92
4875mean corpuscular hemoglobin concentration (MCHC, mean, inv-norm transformed)GCST904754581.92
4876Total lipids in large LDLGCST904980111.91
4877HMOX2 levelsGCST904694661.91
4878Alanine levelsGCST902435821.91
4879GSTA1/PBLD ratioGCST903149941.91
4880Docosahexaenoic acid levelsGCST905022551.91
4881CDKN1A/NCK2 ratioGCST903139731.91
4882IDP dMRI ProbtrackX L3 cgc rGCST900043051.90
4883CNTN4 levelsGCST904688061.90
4884Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T287ECGU0002871.90
4885ZNRF4 levelsGCST904711041.90
48861-stearoyl-GPE (18:0) levelsGCST901997721.90
4887Abnormal heart sounds (PheCode 396)GCST904759161.90
4888Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T371ECGU0003711.90
4889Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T468ECGU0004681.90
4890Systolic blood pressure (MTAG)GCST904490561.90
4891HNRNPAB levelsGCST900886931.90
4892How many years have you or did you smoke cigarettes? (inv-normal transformed)GCST904763901.90
4893Osteoarthrosis | musculoskeletalUKBB000005961.90
4894Degree of unsaturationGCST905027371.89
4895Atrial fibrillation and flutter (PheCode 427.2)GCST900439771.89
4896Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T7ECGA0000071.89
4897CFD levelsGCST904687251.89
4898DTI TBSS MD Cingulum hippocampus LGCST903846091.89
4899PALM levelsGCST904701541.89
4900Bundle branch block (PheCode 426.3)GCST904759561.89
4901Body mass indexGCST900187271.89
4902Illnesses of father - Heart disease | Family historyUKBB000003421.89
4903Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T288ECGU0002881.89
4904APP/HBEGF ratioGCST903133241.89
4905wg lh intensity-contrast banksstsGCST900037931.88
4906ScoliosisFING000012811.88
4907CD46/NECTIN2 ratioGCST903138321.88
4908DTI autoptx L1 fmi tractGCST903851501.88
4909Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T286ECGU0002861.88
4910Waist-hip indexGCST900200271.88
4911Phospholipid levels in large VLDLGCST900928761.88
4912IGFBP6/SMOC2 ratioGCST903151381.88
4913Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T372ECGU0003721.88
4914Left ventricular wall thickness (maximal)GCST904352631.88
4915COL5A1 levelsGCST904688201.87
49161-(1-enyl-palmitoyl)-2-oleoyl-gpc (p-16:0/18:1) levelsGCST902000571.87
4917Marzipan likingGCST900947971.87
4918Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T471ECGA0004711.87
4919AmbidextrousnessGCST900134201.87
4920CA14 levelsGCST904685091.87
4921Descending aorta distensibilityGCST902673861.87
4922Inguinal herniaFING000006811.87
4923AXIN1/MAVS ratioGCST903134141.87
4924ADGRD1 levelsGCST904682351.87
4925Vascular/heart problems diagnosed by doctor - None of the above | Medical conditionsUKBB000008991.86
4926CNTNAP2/DPP10 ratioGCST903141671.86
4927Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T419ECGU0004191.86
4928DorsalgiaFING000004721.86
4929DTI TBSS L1 Superior longitudinal fasciculus LGCST903844691.86
4930Coffee type - Ground coffee (include espresso, filter etc) | DietUKBB000001401.86
4931CKMT1A or CKMT1B levelsGCST904687601.86
4932IDP dMRI ProbtrackX MD ptr lGCST900042381.86
4933Plasma 2-aminobutyrate levels in chronic kidney diseaseGCST902643391.86
4934IDP dMRI ProbtrackX ICVF ilf rGCST900043901.86
4935Concentration of large VLDL particlesGCST904982231.86
49361-methylhistidine metabolite levelGCST906154801.85
4937Total testosterone levelsGCST900121131.85
4938T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 91)GCST903206541.85
4939IDP dMRI TBSS MD Cingulum cingulate gyrus LGCST900040621.85
4940DSG2 levelsGCST904690421.85
4941HMBS/PKLR ratioGCST903150631.85
4942Sleep duration | SleepUKBB000007771.85
4943Prescriptions - gliclazide | sulfonylurea,diabetesUKBB000006841.85
4944Use of hypnotics and sedativesFING000014111.84
4945COQ7 levelsGCST904688311.84
4946Triacylglycerol_54:5_[M+NH4]1+ levelsGCST900605391.84
4947DTI autoptx MD atr r tractGCST903852231.84
4948Histidine levelsGCST904974811.84
4949Alzheimer's disease (MTAG)GCST904490601.84
4950T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 25)GCST903205881.84
4951APOM levelsGCST904683421.84
4952wg lh intensity-contrast parstriangularisGCST900038111.83
4953Coffee type: Ground coffee (include espresso, filter etc) (UKB data field 1508_3)GCST900418031.83
4954Concentration of very large VLDL particlesGCST905006311.83
4955Plasma X-24947 levels in chronic kidney diseaseGCST902668161.83
4956QC rfMRI-to-T1 linear alignment discrepancyGCST900063531.83
4957Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T176ECGU0001761.83
4958Gestational age at birth (child effect)GCST902684211.83
4959aparc-Desikan rh area lingualGCST900031191.83
4960Blood urea nitrogen (BUN, maximum, inv-norm transformed)GCST904751621.83
4961ITGA2 levelsGCST904696341.83
4962ICD10 N91.0, N91.1, N91.2: Amenorrhea, including primary amenorrhea, secondary amenorrhea and unspecified amenorrheaGCST904542191.83
4963Phospholipids in LDLGCST904984321.82
4964Triglyceride levels in HDLGCST900928291.82
4965FLT1/TGFB1 ratioGCST903148571.82
4966Gastric ulcerGCST900186311.82
4967Other peripheral nerve disorders | neurologicalUKBB000006181.82
4968CST3/EFEMP1 ratioGCST903142921.81
4969Triglycerides to Total Lipids in Small VLDL percentageGCST904999221.81
4970Sleep apnea syndromeGCST902673611.81
4971Moderate visual impairment, binocularFING000008311.81
4972T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 114)GCST903206771.81
4973DKKL1 levelsGCST904690001.81
4974Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T186ECGU0001861.81
4975Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T401ECGU0004011.81
4976Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T254ECGU0002541.81
4977KRT19 levelsGCST904697171.81
4978CD160/KLRB1 ratioGCST903137311.81
4979HematocritGCST900023831.80
4980Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T465ECGA0004651.80
4981Alcohol use and misuse (confirmatory factor analysis Factor 22)GCST903093561.80
4982Operation code - carpal tunnel surgery | OperationsUKBB000005531.80
4983Types of transport used (excluding work) - Public transport | Physical activityUKBB000008781.80
4984Left-hemisphere control network to right-hemisphere visual network white-matter structural connectivityGCST903027451.80
4985Free cholesterol levels in chylomicrons and extremely large VLDLGCST905009751.80
4986Lymphangioleiomyomatosis (sporadic)GCST0083111.80
4987Total bilirubin levelsGCST902786431.80
4988Chronic obstructive pulmonary disease x ever smoker interaction (main effect)GCST900165861.80
4989Breast cancerGCST900118041.80
4990TFF3 levelsGCST904708371.79
4991BCAT1 levelsGCST904684271.79
4992IDP T1 SIENAX brain-normalised volumeGCST900024341.79
4993APOF levelsGCST904683391.79
4994CD33 levelsGCST904686251.79
4995Triacylglycerol_50:5_[M+NH4]1+ levelsGCST900604631.79
4996ARHGEF10 levelsGCST904683571.79
4997Average diameter for LDL particlesGCST900928891.78
4998AmygNuclei rh volume Paralaminar-nucleusGCST900026661.78
4999PENK levelsGCST904702081.78
5000Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T233ECGA0002331.78